LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- Herpes Simplex Keratitis Treatment Market Growth Forecast: What To Expect By 2025? The market for treating herpes ...

Transient gene editing of the herpes simplex virus type 1 (HSV-1) using mRNA-based CRISPR was shown for the first time to be effective against herpetic stromal keratitis (HSK) in mice and blocked ...

In a recent study published in the Virology Journal, a group of researchers evaluated the antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced ...

Please provide your email address to receive an email when new articles are posted on . Visual outcomes of children with herpes simplex keratitis were better when patients were seen within 5 days of ...

SAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...

- Treatment with EBT-104 led to complete elimination of viral shedding in 92% eyes of treated rabbits - Excision’s proprietary gene editing technology holds unique, curative potential to address the ...

- Excision’s proprietary gene editing technology holds unique, curative potential to address the leading cause of corneal blindness in the United States - Global incidence of HSV keratitis is ...